The activation of ERK1/2 in tumor cells can either stimulate tumor growth or induce apoptosis, depending on its subcellular localization.[48] In contrast, UA has been reported to directly inhibit tumor growth in vitro,[49] implying that UA‐induced ERK1/2 activation might be cell‐type dependent. This evidence concerns the gene MAPK3 and neoplasm.